UWA logo
UWA logo
Skip Navigation Links
Publication Details
Output Category: C1: Journal Article (Schol Refereed Journal)
Strategic Research Area: Fundamental biomedical and translational approaches to health
TISI Citations: 52 PlumX StatisticsPlumX Statistics
Scopus Citations: 13
Journal Impact: 2.77
All Authors: Moodley, Y, Vaghjiani, V, Chan, J, Baltic, S, Ryan, M, Tchongue, J, Samuel, C, Murthi, P, Parolini, O, Manuelpillai, U Number: 10
UWA Authors: Moodley, Y., Baltic, S., Ryan, M. Number: 2
Title: Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study
Journal: PLoS One   
ISBN/ISSN 1932-6203
Year: 2013
Pages: e69299
Volume: 8
Issue: 8
Full Reference (Harvard Style): Moodley, Y., Vaghjiani, V., Chan, J., Baltic, S., Ryan, M., Tchongue, J., Samuel, C. S., Murthi, P., Parolini, O., Manuelpillai, U. 2013, 'Anti-Inflammatory Effects of Adult Stem Cells in Sustained Lung Injury: A Comparative Study', PLoS One, 8, 8, pp. e69299.
Lung diseases are a major cause of global morbidity and mortality that are treated with limited efficacy. Recently stem cell therapies have been shown to effectively treat animal models of lung disease. However, there are limitations to the translation of these cell therapies to clinical disease. Studies have shown that delayed treatment of animal models does not improve outcomes and that the models do not reflect the repeated injury that is present in most lung diseases. We tested the efficacy of amnion mesenchymal stem cells (AM-MSC), bone marrow MSC (BM-MSC) and human amniotic epithelial cells (hAEC) in C57BL/6 mice using a repeat dose bleomycin-induced model of lung injury that better reflects the repeat injury seen in lung diseases. The dual bleomycin dose led to significantly higher levels of inflammation and fibrosis in the mouse lung compared to a single bleomycin dose. Intravenously infused stem cells were present in the lung in similar numbers at days 7 and 21 post cell injection. In addition, stem cell injection resulted in a significant decrease in inflammatory cell infiltrate and a reduction in IL-1 (AM-MSC), IL-6 (AM-MSC, BM-MSC, hAEC) and TNF-α (AM-MSC). The only trophic factor tested that increased following stem cell injection was IL-1RA (AM-MSC). IL-1RA levels may be modulated by GM-CSF produced by AM-MSC. Furthermore, only AM-MSC reduced collagen deposition and increased MMP-9 activity in the lung although there was a reduction of the pro-fibrogenic cytokine TGF-β following BM-MSC, AM-MSC and hAEC treatment. Therefore, AM-MSC may be more effective in reducing injury following delayed injection in the setting of repeated lung injury. © 2013 Moodley et al.